NantHealth (NH) IPO Opens 15%

Today's IPO for NantHealth (NYSE: NH) opened for trading at $16.11 after pricing 6,500,000 shares of its common stock at a price to the public of $14.00 per share, the middle of the $12.50 - $15.50 range.

Jefferies LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering, and First Analysis Securities Corporation, Canaccord Genuity Inc., and FBR Capital Markets & Co. are acting as co-managers.

NantHealth is a next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. NantHealth‘s unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale, biometric and phenotypic data to track patient outcomes and deliver precision medicine. In addition, NantHealth’s adaptive learning system, CLINICS™, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time.

You May Also Be Interested In